Abstract
The predictive value of limiting dilution analyses (LDA) measuring cytotoxic and helper T-lymphocyte precursor (CTLp and HTLp) frequencies for outcome after stem cell transplantation (SCT) is still a matter of debate. One reason may be that CTLp and HTLp frequencies are determined in peripheral blood mononuclear cells (PBMC) and this responder cell population does not reflect the cell type composition of the graft. We assessed whether CTLp and HTLp LDA can predict complications after human leukocyte antigen (HLA)-identical SCT when CTLp and HTLp frequencies are analyzed in PBMC of the respective stem cell graft [bone marrow (BMMC) or granulocyte colony-stimulating factor (G-CSF)-mobilized PBMC] and compared to PBMC of PB. Host-specific CTLp frequencies measured in 25 patients and HTLp frequencies analyzed in 6 patients were low in all responder cell sources. CTLp and HTLp frequencies seen against HLA-mismatched unrelated third-party cells were high, but third-party-specific CTLp and HTLp frequencies were lower in G-CSF-PBMC than in PBMC (p=0.047 for CTLp frequencies). Host-specific CTLp frequencies analyzed in all responder cell sources did not predict acute or chronic graft-versus-host disease (GVHD). Lower CTLp frequencies were detected in all responder cell sources from patients who relapsed after SCT than in patients without relapse, but the differences between both groups were statistically significant only in PBMC. In conclusion, a significant correlation was detected only between relapse and CTLp frequencies measured in PBMC. The lower frequency of third-party-specific cells in G-CSF-PBMC indicates that the mobilization procedure with G-CSF itself may influence results.
Similar content being viewed by others
Abbreviations
- BMT:
-
Bone marrow transplantation
- CTLp:
-
Cytotoxic T-lymphocyte precursor
- G-CSF:
-
Granulocyte colony-stimulating factor
- GVHD:
-
Graft-versus-host disease
- HTLp:
-
Helper T-lymphocyte precursor
- LDA:
-
Limiting dilution analysis
- PBMC:
-
Peripheral blood mononuclear cells
- PBSC:
-
Peripheral blood stem cells
- SCT:
-
Stem cell transplantation
References
Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A, Bandini G, di Bartolomeo P, Boogaerts M, Bosi A, Carreras E et al. for the Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (1995) Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Blood 86:813–818
Benichou G, Malloy KM, Tam RC, Heeger PS, Fedoseyeva EV (1998) The presentation of self and allogeneic MHC peptides to T lymphocytes. Hum Immunol 59:540–548
Goulmy E (1988) Minor histocompatibility antigens in man and their role in transplantation. Transplant Rev 2:29–34
Kaminski E, Hows J, Man S, Brookes P, MacKinnon S, Hughes T, Avakian O, Goldman JM, Batchelor JR (1989) Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48:608–613
Spencer A, Brookes PA, Kaminski E, Hows JM, Szydlo RM, van Rhee F, Goldman JM, Batchelor JR (1995) Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection. Transplantation 59:1302–1308
Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA (1997) Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transplant 19:1001–1009
Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H (1992) Host-specific interleukin-2-secreting donor T cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 327:1613–1617
Schwarer AP, Jiang YZ, Brookes PA, Barrett JA, Batchelor RJ, Goldman JM, Lechler RI (1993) Frequency of anti-recipient alloreactive helper T cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 341:203–205
Leung AY, Kwok J, Lie AK, Chen FE, Liang R (2001) Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings. Haematologica 86:652–656
Russel CA, Heilmann C, Madsen HO, Vindelow LL (2001) The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation. Bone Marrow Transplant 27:949–958
Weston LE, Geczy AF, Farrell C (1997) Donor helper T cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. Transplantation 64:836–841
Lachance S, Le Gouvello S, Roudot F, Kuentz M, Bernaudin F, Beaujean F, Bierling P, Cordonnier C, Farcet JP, Vernant JP (1997) Predictive value of host-specific donor helper T cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies. Transplantation 64:1147–1152
Van der Meer A, Allebes WA, Voorter CE, van den Berg-Loonen EM, Schattenberg AV, de Witte TJ, Joosten I (1998) Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT. Bone Marrow Transplant 22:1049–1055
De Bueger M, Bakker A, Bontkes H, van Rood JJ, Goulmy E (1993) High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. Bone Marrow Transplant 11:363–368
Fussel ST, Donnellan M, Cooley MA, Farrell C (1994) Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 57:673–676
Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM (2000) T cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Transplantation 70:488–493
Healey G, Schwarer AP (2002) The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilized peripheral blood stem cell transplantation. Bone Marrow Transplant 30:341–346
Nachbaur D, Eibl B, Kropshofer G, Meister B, Mitterschiffthaler A, Schennach H, Fischer G, Kopp M, Gunsilius E, Gastl G (2002) In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res 11:731–737
Storb R, Deeg HJ, Whitehead J, Applebaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 314:729–735
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295–301
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GF, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–211
Taswell C (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614–1619
Singhal S, Powles R, Kulkarni S, Treleaven J, Sirohi B, Millar B, Shepherd V, Saso R, Rowland A, Long S, Cabral S, Horton C, Mehta J (2000) Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Bone Marrow Transplant 25:501–505
Rondelli D, Raspadori D, Anasetti C, Bandini G, Re F, Arpinato M, Stanzani M, Morelli A, Baccini C, Zaccaria A, Lemoli RM, Tura S (1998) Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 22:631–637
Hoffmann T, Theobald M, Bunjes D, Weiss M, Heimpel H, Heit W (1993) Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. Bone Marrow Transplant 12:1–8
Hladik F, Kolbe K, Irschick EU, Aman MJ, Gerken G, Färber L, Liehl E, Peschel C, Aulitzky WE, Huber C (1993) IL-2, IL-3, and IFN-gamma affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p). Ann Hematol 67:67–74
Sugimori N, Nakao S, Yachie A, Niki T, Takami A, Yamazaki H, Miura Y, Ueda M, Shiobara S, Matsuda T (1999) Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin− T cells. Bone Marrow Transplant 23:119–124
Gyger M, Stuart RK, Perreault C (2000) Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Bone Marrow Transplant 26:1–16
Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta analysis. J Clin Oncol 19:3685–3691
Bunjes D, Theobald M, Nierle T, Arnold R, Heimpel H (1995) Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. Bone Marrow Transplant 15:727–732
Horan JT, Liesveld JL, Fernandez ID, Lyman GH, Phillips GL, Lerner NB, Fisher SG (2003) Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. Bone Marrow Transplant 32:293–298
Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ (1991) Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Bone Marrow Transplant 8:253–258
Kircher B, Hack E, Dickinson A, Wang X, Oudshoorn M, Goulmy E (2004) Towards functional transplant donor matching by measurement of granzyme A and granzyme B production (abstract). Bone Marrow Transplant 33:S179
Van Besouw NM, Vaessen LMB, Zuijderwijk JM, van Vliet M, Ijzermans JNM, van der Meide PH, Weimar W (2003) The frequency of interferon-gamma producing cells reflects allo-reactivity against minor histocompatibility antigens. Transplantation 75:1400–1404
Barrett JA, Rezvani K, Solomon S, Dickinson AM, Wang XN, Stark G, Cullup H, Jarvis M, Middleton PG, Chao N (2003) New development in allotransplant immunology. Hematology (Am Soc Hematol Educ Program):350–371
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kircher, B., Niederwieser, D., Gächter, A. et al. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation. Ann Hematol 83, 566–572 (2004). https://doi.org/10.1007/s00277-004-0886-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0886-3